Health Minister addresses general debate at 79th Session of World Health Assembly
Georgia’s Minister of Health, Mikheil Sarjveladze, delivered a speech at the general debate held as part of the 79th session of the World Health Assembly.
The Minister spoke about the healthcare reforms implemented in Georgia, noting that following the introduction of the universal healthcare programme, over 95 per cent of the population now has access to state-funded services.
According to the Minister, the pharmaceutical reforms carried out in recent years, including the introduction of reference pricing, have significantly improved access to medicines.
“Over the course of the past decade, we have continued to strengthen our healthcare system through reforms aimed at improving accessibility, quality, and financial protection for the population. Since the launch of the universal healthcare programme, more than 95 per cent of the population has access to state-funded healthcare services. Access to essential medical care has been considerably expanded, whilst out-of-pocket payments by citizens have decreased substantially. In recent years, we have implemented significant pharmaceutical reforms, including the introduction of reference pricing mechanisms and managed entry agreements, which have improved access to medicines and enabled us to abolish the annual limits on medications for the treatment of oncological and chronic diseases under state programmes,” Mikheil Sarjveladze declared.
The Minister also spoke about the ongoing reform of primary healthcare, which is grounded in prevention, quality care, and patient-centred services.
Mikheil Sarjveladze noted that the reform encompasses new funding mechanisms, digital transformation, and the introduction of quality standards and outcomes-based approaches.
Participating in the 79th session of the World Health Assembly alongside Mikheil Sarjveladze are: Zaza Lominadze, Chairman of the Parliamentary Committee on Healthcare and Social Affairs; Lela Sulaberidze, Head of the Strategic Development and Analytics Department of the Ministry of Health; and Aleksandre Maisurаdze, Permanent Representative of Georgia to the United Nations Office in Geneva and other international organisations.
Other News
Health Minister thanks parents for constructive talks, joint working group critically important to secure DMD medication
04.06.2026.17:52
“Work will continue within the working group framework. This is critically essential, ensuring that we can best accommodate and protect the interests of children and patients, not only regarding medications but in all other areas as well,” the Minister of Health of Georgia, Mikheil Sarjveladze, stated during a briefing following a meeting with the parents of children with Duchenne muscular dystrophy.
Sarjveladze also extended his personal thanks to the parents for their constructive engagement throughout the process.
“I wish to join in expressing gratitude for the constructive approach shown by the parents. This was truly vital in reaching the decisions we have reached today, and it is precisely the kind of collaborative spirit that is needed going forward. I would also like to thank the Prime Minister for his personal involvement. We have been in consultation on these matters for quite some time, and it was of great importance that the process has been brought to where it stands today.
Work will continue in the working group format. This is critically important and necessary to have the fullest possible capacity to meet and protect the best interests of the children and patients concerned, not only in the area of medications, but across every other area as well. Parents and patients will be the first to be informed of any new developments. Naturally, the wider public will also have full access to all relevant information,” said Sarjveladze.
Earlier, Prime Minister Irakli Kobakhidze announced, following the meeting with the parents of children with Duchenne muscular dystrophy, that a working group would be established with the participation of the Ministry of Health and the parents, tasked with actively addressing the provision of specific medications for children affected by the condition.